F/M Investments’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.4M | Buy |
66,624
+7,226
| +12% | +$1.34M | 0.45% | 42 |
|
|
2025
Q1 | $12.4M | Buy |
59,398
+27
| +0% | +$5.66K | 0.5% | 42 |
|
|
2024
Q4 | $10.6M | Buy |
59,371
+7,226
| +14% | +$1.28M | 0.39% | 53 |
|
|
2024
Q3 | $19M | Sell |
52,145
-3,711
| -7% | -$1.36M | 0.6% | 32 |
|
|
2024
Q2 | $9.56M | Buy |
55,856
+54,351
| +3,611% | +$9.3M | 0.35% | 99 |
|
|
2024
Q1 | $274K | Buy |
1,505
+145
| +11% | +$26.4K | 0.19% | 57 |
|
|
2023
Q4 | $211K | Sell |
1,360
-71
| -5% | -$11K | 0.12% | 80 |
|
|
2023
Q3 | $213K | Buy |
+1,431
| New | +$213K | 0.16% | 68 |
|
|
2023
Q2 | – | Sell |
-1,275
| Closed | -$203K | – | 75 |
|
|
2023
Q1 | $203K | Hold |
1,275
| – | – | 0.2% | 60 |
|
|
2022
Q4 | $206K | Buy |
+1,275
| New | +$206K | 0.25% | 50 |
|
|
2022
Q3 | – | Sell |
-1,962
| Closed | -$221K | – | 33 |
|
|
2022
Q2 | $221K | Sell |
1,962
-11
| -0.6% | -$1.24K | 0.17% | 59 |
|
|
2022
Q1 | $320K | Buy |
1,973
+9
| +0.5% | +$1.46K | 0.26% | 43 |
|
|
2021
Q4 | $266K | Hold |
1,964
| – | – | 0.19% | 54 |
|
|
2021
Q3 | $212K | Buy |
1,964
+2
| +0.1% | +$216 | 0.15% | 75 |
|
|
2021
Q2 | $221K | Sell |
1,962
-1,685
| -46% | -$190K | 0.17% | 59 |
|
|
2021
Q1 | $395K | Buy |
3,647
+1,625
| +80% | +$176K | 0.31% | 51 |
|
|
2020
Q4 | $217K | Buy |
+2,022
| New | +$217K | 0.19% | 52 |
|